Mesh Bio

17 December 2025

Insights

Investing in health tech to tackle Indonesia’s greatest challenges

The COVID-19 pandemic has exposed critical gaps in Indonesia’s healthcare infrastructure, revealing structural and systemic shortcomings requiring scalable solutions. While revolution in this highly regulated sector does not happen overnight, we are now witnessing a pivotal shift driven by the Omnibus Health Law (Law No.…

Artificial intelligence AI Application in Indonesia kecerdasan buatan|Artificial Intelligence in Indonesia - The current state and its opportunities

25 February 2025

Insights

Artificial Intelligence in Indonesia: The current state and its opportunities

Most of the breakthroughs in artificial intelligence (AI) development are already happening in many countries, and in Indonesia, these innovations are also on the rise. With a young, tech-savvy population and favorable macroeconomic trends, Indonesian companies are starting to adopt and advance on AI’s vast…

Indonesia healthcare digital transformation east ventures summit 2024

24 September 2024

Insights

What’s next in Indonesia’s healthcare landscape: Digital transformation, preventive care, and early detection

The Indonesian healthcare landscape has improved significantly in the past decade. It has strengthened access to funding through the successful rollout of the BPJS Kesehatan, or universal healthcare, and the successful reforms implemented through the Omnibus Law that we will see in the coming years.…

19 July 2024

From Portfolios

How Mesh Bio uses digital twin to predict disease 3 years early

Mesh Bio is transforming the healthcare landscape through its proprietary digital twin technology and predictive analytics platform, built at the intersection of computational biology and artificial intelligence. By utilizing sophisticated mathematics to model internal biological mechanisms, Mesh Bio enables physicians to visualize a patient’s unique…

30 January 2024

Press Release

Mesh Bio raises US$3.5 million of Series A funding led by East Ventures, to make its digital twin technologies available at scale

Mesh Bio, a Singapore-based health deep tech startup transforming chronic disease management through predictive analytics, announced today that it has raised US$3.5 million in Series A financing led by East Ventures, a pioneering and leading sector-agnostic venture capital firm focusing on Southeast Asia. This round…

12 October 2023

Press Release

Mesh Bio, a health deep tech startup, secured investment from East Ventures

Mesh Bio, a Singapore-based health deep tech startup in transforming chronic disease management through predictive analytics, announced that it had raised an undisclosed amount of funding from East Ventures, a pioneering and leading sector-agnostic venture capital firm focusing on Southeast Asia. The funding will be…

About us

About East Ventures

Reports

East Ventures – Digital Competitiveness Index 2025

AI-first: Decoding Southeast Asia trends

Sustainability Report 2025

News & media

Latest news

Highlighted video

Mesh Bio

Investing in health tech to tackle Indonesia’s greatest challenges

Artificial Intelligence in Indonesia: The current state and its opportunities

What’s next in Indonesia’s healthcare landscape: Digital transformation, preventive care, and early detection

How Mesh Bio uses digital twin to predict disease 3 years early

Mesh Bio raises US$3.5 million of Series A funding led by East Ventures, to make its digital twin technologies available at scale

Mesh Bio, a health deep tech startup, secured investment from East Ventures

Singapore

Indonesia

Japan

About East Ventures

Mesh Bio

Stay ahead with our Monthly Digest

Singapore

Indonesia

Japan